Miyata N, Yamaura H, Tanaka M, Muramatsu M, Tsuchida K, Okuyama S, Otomo S
Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Life Sci. 1993;52(18):PL181-6. doi: 10.1016/0024-3205(93)90115-j.
We investigated the effects of VA-045, an apovincaminic acid derivative, on isolated blood vessels. VA-045 (10(-7)-10(-5) M) and vinpocetine (10(-7)-10(-5) M) inhibited the 64 mM KCl-induced and 10(-6)M norepinephrine (NE)-induced contraction of rat aortic strips. VA-045 (10(-7)-10(-4) M) and vinpocetine (10(-7)-10(-4) M) inhibited the activity of cyclic AMP and cyclic GMP phosphodiesterase in porcine coronary artery. VA-045 (3 x 10(-9-3 x 10(-6) M) relaxed the 64 mM KCl-induced contraction of the canine basilar artery without affecting the peripheral arteries. These results indicate that VA-045 selectively dilates canine cerebral artery, and that it may be a useful agent for the treatment of cerebrovascular diseases such as stroke.
我们研究了阿朴长春胺酸衍生物VA - 045对离体血管的作用。VA - 045(10⁻⁷ - 10⁻⁵M)和长春西汀(10⁻⁷ - 10⁻⁵M)抑制64 mM氯化钾诱导的以及10⁻⁶M去甲肾上腺素(NE)诱导的大鼠主动脉条收缩。VA - 045(10⁻⁷ - 10⁻⁴M)和长春西汀(10⁻⁷ - 10⁻⁴M)抑制猪冠状动脉中环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)磷酸二酯酶的活性。VA - 045(3×10⁻⁹ - 3×10⁻⁶M)可舒张64 mM氯化钾诱导的犬基底动脉收缩,而不影响外周动脉。这些结果表明,VA - 045可选择性扩张犬脑动脉,可能是治疗中风等脑血管疾病的有效药物。